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When a field shares the consensus that a particular phenomenon does NOT occur, this may reflect extensive
experimental investigations with negative outcomes, or may represent the “common sense” position based on
current knowledge and established ways of thinking. The current consensus of the RNA field is that eukaryotic
Argonaute (Ago) proteins employ RNA guides and target other RNAs. The alternative – that eukaryotic Ago has
biologically important interactions with DNA in vivo – has not been seriously considered, in part because the only
role contemplated for DNA was as a guide strand, and in part because it did not seem plausible that any natural
source of suitable DNAs exists in eukaryotic cells. However, eukaryotic Argonaute domains bind DNA in the test
tube, and several articles report that small inhibitory double-stranded DNAs do have the ability to silence target
RNAs in a sequence-dependent (though poorly characterized) manner. A search of the literature identified potential
DNA binding partners for Ago, including (among others) single-stranded DNAs residing in extracellular vesicles, and
cytoplasmic satellite-repeat DNA fragments that are associated with the plasma membrane and transcribed by
Pol II. It is interesting to note that both cytoplasmic and extracellular vesicle DNA are expressed at greatly elevated
levels in cancer cells relative to normal cells. In such a pathological scenario, if not under normal conditions, there
may be appreciable binding of Ago to DNA despite its lower affinity compared to RNA. If so, DNA might displace
Ago from binding to its normal partners (miRNAs, siRNAs and other short ncRNAs), disrupting tightly controlled
post-transcriptional gene silencing processes that are vital to correct functioning of a normal cell. The possible
contribution to cancer pathogenesis is a strong motivator for further investigation of Ago-DNA binding. More
generally, this case underscores the need for better informatics tools to allow investigators to analyze the state of a
given scientific question at a high-level and to identify possible new research directions.
Reviewers: This article was reviewed by Eugene Koonin, Kira S. Makarova, Alexander Maxwell Burroughs (nominated
by L Aravind), and Isidore Rigoutsos.
Open peer review: Reviewed by Eugene Koonin, Kira S. Makarova, Alexander Maxwell Burroughs (nominated by
L Aravind), and Isidore Rigoutsos. For the full reviews, please go to the Reviewers’ comments section.
Keywords: Consensus, Hypothesis assessment, Scientific discovery, DNA interference, Cytoplasmic DNA, RNA
interferenceBackground
Analyses of new emerging scientific research trends are
almost always done retrospectively, rather than prospect-
ively. Yet we can only assert that we understand a phe-
nomenon if we can predict its occurrence at a given
time and place in the future. How might we recognize
situations in which a new trend has not yet started? It is
one thing to predict the Beatles will be stars after they
have appeared on the Ed Sullivan show, quite another to
do so while they are playing in Hamburg.* Correspondence: neils@uic.edu
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article, unless otherwise stated.One possible strategy is to look for fields in which new
enabling methods and tools have just been introduced.
Another is to focus on situations in which there is great
activity and great turmoil – e.g., TAUists vs. BAPtists in
Alzheimer disease, or proteins vs. nucleic acids in prion
disease – where the scientific community openly discus-
ses, and attempts to reconcile, controversies based on
disparate observations or experimental analyses. How-
ever, we suggest that new trends may also be situated in
the absence of controversy: Namely, when the mains-
tream of a field shares the consensus that a particular
phenomenon does NOT occur, and papers stating the
negative consensus do not feel that it is necessary toed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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tions to back up the assertion. This is a sign that the
negative consensus is not the result of intensive expe-
rimental investigations that tested and ruled out the
phenomenon exhaustively, but rather represents the
“common sense” position based on current knowledge
and established ways of thinking. Since these might
readily be overturned in the light of new empirical find-
ings, they represent situations in which a small input of
new data might have a large output in terms of new
lines of investigation. This is somewhat like predicting
forest fires by identifying areas that are experiencing
very dry conditions – nothing at all has happened yet,
but a single match could spread flames like – well, like
wildfire!
The starting point for our analysis is the publication
of two breakthrough papers (Olovnikov et al. [1]; Swarts
et al. [2]), which provided experimental validation of
predictions made previously by Makarova et al. [3], namely,
that prokaryotic Argonaute proteins are able to bind
DNA and to carry out DNA-guided as well as RNA-
guided mediated cleavage of DNA molecules (“DNA
interference”) [1-3]. This appears to provide a form of
protection of a bacterial cell against foreign invading
plasmids and possibly other sources of foreign DNA.
We were intrigued that both papers, as well as numer-
ous following news-and-views articles, all stated or im-
plied that eukaryotic Argonaute proteins only interact
with RNA molecules and not with DNA. For example:
“eukaryotic Ago proteins exclusively use ssRNA guides”
[2]; “Eukaryotic Argonautes bind small RNAs and use
them as guides to find complementary RNA targets and
induce gene silencing” [1]; “several prokaryotic Agos,
unlike their eukaryotic homologs, have the remarkable
ability to bind single-stranded DNA guides in vitro and
are capable of utilizing them for cleavage of RNA tar-
gets” [4]; “subsequent structural work with eukaryotic
Argonautes continued to bolster the RNA guide–RNA
target model” [5]; “the ability of eukaryotic Argonautes
to incorporate ssRNAs as guide molecule is a universal
activity that was inherited from the primordial ancestral
Argonaute protein” [6].
These are not merely statements of scientific consen-
sus regarding the nature of guides for eukaryotic Ago,
but also serve rhetorical functions. For example, they
heighten the contrast between mammalian and prokary-
otic Argonautes, and emphasize the importance and
novelty of the DNA interference phenomenon. Moreover,
they also have the unintended effect of warning away
readers who might naively wonder whether eukaryotic
Ago proteins are also capable of interacting with DNA in
any biologically relevant fashion at all. Like a policeman,
these statements say: “Move along, folks, show’s over;
nothing to see here. Move along quickly now!”Evidence for interactions of Argonaute with DNA and
DNA-like nucleic acids
Over the past decade, eukaryotic Argonaute proteins
have shown a steady increase in the number of its well-
documented protein and RNA binding partners, its sub-
cellular locales and its biological functions [6,7]. Not
only does Ago interact with a variety of classes of short
RNAs [6], it binds longer structured ncRNAs such as
pre-miRs and certain tRNAs, as well as single stranded
RNAs [8,9]. In fact, Ago can bind directly to mRNAs
[10] and can inhibit protein translation even in the ab-
sence of RNA guide strands, e.g. when tethered to the
mRNA [11] or when using Smaug as a protein-based
guide [12].
It is not absurd to wonder if eukaryotic Ago might
interact with DNA as well, since isolated domains of
Argonaute proteins do bind DNA in the test tube. For
example, the human Ago2 MID domain, which binds to
the 5′ end of small RNAs, shows no strong binding pref-
erence towards the sugar conformation in the nucleic
acids. RNA and DNA have comparable dissociation con-
stants (Kd = 35 μM for DNA, 53 μM for RNA) [13]. In
addition, the crystal structure of human Ago2 reveals
that it does not have any direct hydrogen bonds to the
2′ hydroxyl groups of the guide strand for RNA recogni-
tion, which may explain why DNA bases and 2′ fluoro
substitutions are well tolerated in the antisense strand of
siRNAs [14]. Drosophila melanogaster Ago2 has similar
binding affinity to 21nt ssDNA and ssRNA of the same
sequence, and recognizes 21 bp dsDNA [15,16]. The
PAZ domain of D. melanogaster Ago1 shows binding to
26 nt ssDNA, albeit with lower affinity than to the equiva-
lent ssRNA sequence [17].
Argonaute proteins also bind DNA-like nucleic acids.
Experiments using 21 nt siRNA with substitutions of 2′-
fluorocytidine and 2′-fluorouridine in the antisense
strand showed only slight decrease in RNAi in HeLa
cells when compared to control siRNA, showing that the
2′-OH is not needed for RNAi [18]. Further modifi-
cations of the antisense strand with inclusion of deo-
xyguanine and deoxyadenine also do not affect RNAi
significantly. However, replacing either the entire anti-
sense strand or both strands with DNA abolishes RNAi
completely [18]. DNA-modified-siRNA-dependent gene
silencing requires TRBP2 and PACT, which bind to
dsRNA, but not normally to dsDNA [19]. This might
be one reason why, even though Ago2 may be able to
bind ssDNA/dsDNA, DNA-guided RNA interference is
not strongly induced.
siDNAs
In contrast to the negative finding of Chiu and Rana
[18], three articles report that double-stranded DNA
(siDNA) can silence viral and cellular RNAs in living
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siRNAs vs. siDNAs and found that both caused significant
silencing of its target (G6PD) in a sequence dependent
manner in CHO cells, with similar kinetics, although
siDNAs produced less inhibition at equal doses [20]. b)
Nowak and coworkers reported that double-stranded
DNA (siDNA) is able to reduce expression of a viral
RNA in tobacco plants, whereas a scrambled dsDNA
sequence is inactive. In human HeLa cells, siDNA
reduced expression of a co-transfected reporter RNA
by 50% and 78%, using 25nM and 100nM of siDNA,
respectively (though they did not establish whether the
effects of siDNA in HeLa cells are sequence-specific)
[21]. siDNA is less potent than siRNA, which reduced
expression by over 80% at only 5nM [21]. Although the
role(s) of Ago in these siDNA effects have not been in-
vestigated, they do provide possible examples in which
DNA might act as a guide for Ago and deserve further
scrutiny. c) Finally, Moelling et al. [22] employed a par-
tially double-stranded DNA oligonucleotide to target
and cleave a particular viral RNA sequence in HEK293
cells. In this paradigm, cellular RNAse H appears to
mediate the cleavage of target RNA within the DNA/
RNA hybrid under normal conditions. However, when
RNAse H is knocked down and Ago2 is overproduced
via transfection, then Ago2 protein could also mediate
cleavage of the RNA target (presumably via its PIWI
domain which is RNAse H-like) [22]. This example
shows that Ago might potentially participate in RNA si-
lencing of DNA/RNA hybrids, even if it does not use
the DNA as a guide for target recognition.
Co-expression of Argonaute proteins with DNA in
different subcellular locales
Probably the most important reason that eukaryotic Ago-
DNA interactions have not been taken seriously is that, as
stated by Olovnikov et al. [1,4]: “small DNAs have not
been found in association with Argonaute proteins in
eukaryotes. Natural short single-stranded DNAs, to our
knowledge, have not been found in any cellular pathway,
though short DNA sequences, Okazaki fragments, paired
with long DNA are synthesized during replication of the
lagging-DNA strand.” Although no one has identified very
short DNAs (~21 nt) in eukaryotes of the type expected
to be guides, no one has really looked for them either!
When we carried out a search of the literature, we were
able to identify a number of studies that have described
DNA, relatively short DNA fragments (50-500 bp), and/or
single-stranded DNAs as being naturally expressed in a
number of biological locales:
a) DNA in the nucleus. Ago proteins are known to
enter the nucleus and perform several functions
there, such as directing transcription, centromereheterochromatin formation, alternative splicing, and
DNA damage repair [23]. It is thought that Ago
forms a complex with miRNAs and siRNAs that
interact with RNAs (e.g. promoter-associated
RNAs) transcribed at these sites [7]. To our
knowledge, no one has investigated whether Ago
binds genomic DNA directly. However, single
stranded DNA may be accessible not only during
replication (as mentioned above) but also at active
promoters, where portions of genomic DNA are
unwound and might conceivably be targeted by
Ago/RNA complexes. This might regulate the rate
or progression of transcription at these sites, even
if the DNA is not cleaved. It has also been
proposed that Ago-miRNA complexes might bind
to specific double-stranded sites on promoters to
form triple-helix structures [24].
b) DNA in the cytoplasm. Non-mitochondrial DNA
was first observed in cytoplasm over 40 years ago.
After demonstrating that cytoplasmic DNA does not
simply consist of nucleosomes or other fragments
associated with dead or dying cells, at least two
pools of cytoplasmic DNA were characterized –
one associated with microsomal fractions, and one
associated with the plasma membrane. Cytoplasmic
DNA levels vary in a cell line-dependent fashion
[25]. Further studies showed that cytoplasmic DNA
represents 1-2% of total cellular DNA in myeloma
cells. Structurally, more than half of cytoplasmic
DNA had a sedimentation constant of 6-8S, the
remaining being more heterogeneous (12S to 40S)
[26]. Cytoplasmic non-mitochondrial DNA with size
in the range of 50-500 bp was observed in mouse
L929 and Ehrlich ascites tumor cells, and some
cytoplasmic DNA sequences, when cloned and
transferred to non-tumor cells, could immortalize
recipient cells [27]. Density and cloning analyses
suggest that these sequences may be partially single-
stranded and/or associated with RNA or metallo-
proteins [27]. Challen and Adams [28] found that a
portion of cytoplasmic DNA is short (~100 nt) and
single-stranded [28]. Lerner et al. [29] observed
plasma membrane-bound cytoplasmic DNA
accounted for 0.5% of total DNA content in
continuously growing human diploid lymphocytes
(WIL2 cells) [29]. They found that more than 99%
of the DNA molecules are linear and appear to be
oriented with respect to the membrane. More
recently, deep sequencing revealed that this
DNA originates mostly from centromeric and
pericentromeric chromosomal regions [30], with
particularly strong enrichment in 171-bp α-satellite
repeats (ALRs) that are transcribed by co-localized
Pol II. Some studies of microsomal-associated DNA
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repetitive sequences [31].
Many cell types have a surveillance system that detects
the presence of cytoplasmic DNA (as well as dsRNA),
which can activate an innate immune signaling cascade
that involves the production of type I IFN [32-34]. Cer-
tainly, cytoplasmic DNA can be induced under patho-
logical conditions such as viral infection, inflammation
and oxidative damage, but these arise from different sour-
ces than naturally occurring cytoplasmic DNA [35-37],
and it is not clear whether the latter would necessarily
elicit any signaling response under normal conditions.
(Note that similar worries had been raised in objection to
the presence of naturally occurring dsRNA in cytoplasm,
yet siRNAs and longer RNA hybrids are both naturally
expressed in situations that do not elicit an interferon
response (reviewed in [38,39]).
Interestingly, DNA with features similar to cytoplas-
mic DNA was found to be extruded from living cells in
association with RNA, proteins and lipids; this DNA is
relatively resistant to DNAse, and could be taken up by
recipient cells [40]. The extracellular DNA complexes
are described as smaller and having lighter buoyant
density than microvesicles and exosomes (see below),
and may be more akin to lipoprotein particles and other
nucleoprotein complexes shed from cells, some including
Argonaute proteins, which are known to bind miRNAs
and transport them to recipient cells [41]. To our know-
ledge, no one has immunopurified Ago proteins from
either cytoplasm or conditioned cell medium to learn if
Ago is associated with DNA.
c) DNA in extracellular vesicles (microvesicles (MVs)
and exosomes). Argonaute proteins are components
of microvesicles and exosomes, and have been
reported to bind to small RNAs expressed therein
[42,43]. Exosomes express a mix of miRNAs and
other small RNAs, longer ncRNAs and mRNAs
which appear to be transferred to recipient cells, and
may be translated or regulate translation within
recipient cells [44-46]. DNA is well characterized as
a component of prokaryotic outer membrane
vesicles (OMVs; see Endnotea) and a variety of
reports indicate that DNA is also contained within
mammalian extracellular vesicles:
Prostate cells secrete vesicles called prostasomes that
contain DNA fragments from ~5 kb up to 13 kb; these
are derived from the entire chromosomal genome [47].
Prostasomes are able to fuse with sperm cells, introdu-
cing exogenous DNA and RNA into sperm cells [48-50].
Human vascular smooth muscle cells also release
extracellular vesicles containing dsDNA (1-20 kb) that istaken up, localized in the nucleus and translated into
functional protein by other cells [51]. Vesicle populations
are not homogeneous regarding size, protein composition,
buoyant density and electron density, suggesting that the
DNA content might also be heterogeneous [52]. In fact,
DNA immune-labeling studies showed that only about
10% of the exosomes released by B16-F10 murine melan-
oma cells carry detectable DNA [53].
Human cancer cells release vesicles that contain geno-
mic DNA, sometimes in much higher amounts than
normal cells. Balaj et al. [54] reported that MVs from can-
cer cells overexpress c-Myc gene sequences and have
elevated levels for both RNA and DNA (8- to 45-fold and
10- to 25-fold, respectively) when compared to normal
fibroblasts [54]. Exosomal DNA content is 20-fold higher
in tumor exosomes than in two normal stromal fibroblast
lines and exosome-derived DNA abundance varies widely
across cancer cell lines [53]. Single-stranded DNA is ex-
pressed in glioblastoma and medulloblastoma cell-derived
MVs and far more abundant than in normal cells [54].
Inhibition of DNA replication with mimosine, an alkaloid
that arrests the cell cycle in late G1 phase, before DNA
replication [55], results in a decrease of 50% in DNA yield
from MVs, raising the possibility that some of the ssDNA
may be fragments generated during DNA replication and
mitosis [54]. Alternatively, some of the exosomal DNA
may be derived from reverse transcription of cellular
RNAs, as supported by the high reverse transcriptase
activity in tumor-derived microvesicles [54].
In contrast to Balaj et al [54], Thakur and coworkers
showed that DNA associated with several types of tumor-
derived exosomes was digested by dsDNA-specific DNase,
but not by ssDNA nuclease, indicating that most of the
exosomal DNA is double-stranded [53]. Sequencing of
murine melanoma-derived exosomal DNA revealed that it
derived from the entire genome in an unbiased manner,
representing sense and antisense strands of gene-coding
regions, as well as intergenic regions; no fragments were
significantly enriched or depleted and no mitochondrial
DNA was detected [53]. Similarly, exosomes derived from
pancreatic cancer cell lines, as well as from pancreatic
cancer patients’ serum, contain large dsDNA fragments
of more than 10 kb that uniformly mapped back to all
chromosomes [56].
Not all extracellular DNA is vesicular, and some may
derive from necrotic and apoptotic cells, which may
complicate analyses if not taken into account. However,
all the studies reviewed here performed some sort of
treatment to the extracellular vesicles prior to DNA ex-
traction in order to diminish contamination by externally-
bound DNA. The most common procedure is DNase
treatment, which presumably degrades unprotected DNA
[47,54,56,57]. An elegant method used by some for deter-
mining the origin of exosomal DNA is treating exosomes
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meate the membrane and another that cannot (acridine
orange and propidium iodide, respectively). For both pros-
tasomes and cardiomyocyte-derived microvesicles, flow
cytometry analysis showed that vesicles treated with acrid-
ine orange exhibited enhanced fluorescence, while the
ones treated with propidium iodide had florescence sig-
nals compared to untreated control. This implies that the
DNA is in fact inside the vesicles, not simply attached to
the membrane from the outside [47,52].
It is interesting to note that both cytoplasmic DNA
and extracellular vesicle DNA are expressed at greatly
elevated levels in cancer cells relative to normal cells. In
such a pathological scenario, if not under normal condi-
tions, there may be appreciable binding of Ago to DNA
despite its lower affinity compared to RNA. If so, DNA
might displace Ago from binding to its normal partners
(miRNAs, siRNAs and other short ncRNAs), disrupting
tightly controlled post-transcriptional gene silencing
processes that are vital to correct functioning of a nor-
mal cell. The possible contribution to cancer pathogen-
esis is a strong motivator for further investigation of
Ago-DNA binding.
Conclusion
The current consensus of the RNA field is that eukar-
yotic Argonaute proteins employ RNA guides and target
other RNAs. The alternative – that eukaryotic Ago has
biologically important interactions with DNA – has not
been seriously considered, in part because the only role
contemplated for DNA was as a guide strand, and in
part because it did not seem plausible that any natural
source of suitable DNAs exists in eukaryotic cells. When
we took a peek into the literature in search of potential
DNA binding partners for Ago, we found an assortment
of odd characters worthy of the Exploding Plastic Inevit-
able, whose very existence (let alone possible functions)
are poorly characterized and hard to fit within existing
scientific frameworks: siDNAs; single-stranded DNAs
residing in extracellular vesicles; and satellite-repeat DNA
fragments that are associated with the plasma membrane
and transcribed by Pol II, to name three. If Ago were to be
shown to bind to any of these forms of DNA in vivo, espe-
cially in states of cancer, this would go a long way towards
integrating these entities into the mainstream. Therefore,
we predict that the field of eukaryotic (particularly mam-
malian) Ago-DNA binding and functions, which currently
does not exist at all, has the potential to rise and become
prominent in the near future.
Implications for the informatics of scientific discovery
A second underlying purpose in writing the present article
is to evaluate the literature surrounding a specific situ-
ation in biology, with an eye towards understanding theneeds and requirements for developing new informatics
tools that can assist investigators in scientific discovery
[58-61]. The situation of negative consensus – that is, the
consensus of a field that a given phenomenon does NOT
occur – would seem to be quite common in science. Yet
to our knowledge, no one has studied how often it occurs,
nor has it been emphasized as a pivotal “weak link” in the
chain of existing knowledge. There is no search tool to
help scientists identify scientific statements that reflect a
negative consensus, nor to help them assess whether the
negative consensus has been reached due to (vs. in the
absence of) direct, intensive experimental testing. One
possible way forward is to undertake text mining of
BioNØT, a database of negated sentences taken from the
biomedical literature [62]. Negative statements that occur
repeatedly in the literature may be regarded as candidates
to reflect scientific negative consensus, and can be further
investigated in their original contexts. We hope that
further analyses of the negative consensus can assess its
value generally in identifying potential new promising
lines of investigation before they begin to emerge.
The Arrowsmith two-node search tool [59,60] is
designed to identify items or concepts that can bridge
two fields of study in a meaningful way, especially if the
two fields are apparently disparate and have little direct
overlap in terms of shared articles, authors or citations.
However, the present case study is not ideal for analy-
sis by Arrowsmith, for several reasons. The two fields
“eukaryotic (or mammalian) Argonaute” and “DNA” are
far from disparate; furthermore, the tool is intended to be
applied to topically focused literatures [59], whereas DNA
is a voluminous and far-ranging literature. One of the
potential bridging terms that we identified by manual
searching in the present case is “cytoplasmic” – but this is
rather nondescript and general, and the Arrowsmith tool
assigns it an estimated probability of relevance of 0.0 that
would not invite further scrutiny.
PubMed and other information retrieval tools can find
articles that explicitly discuss “Argonaute AND DNA”
together in the same article, and arguably, one can rely
on recent review articles to summarize the predominant
themes, core knowledge and obvious gaps that call for fur-
ther research. However, there is no search tool to help sci-
entists characterize the “penumbra” of any given scientific
question – that is, to collect and sort through the findings
that are untidy, incidental, neglected, un-replicated, un-
cited, and/or otherwise not fitting inside the mainstream
areas of study. Refs. [21,22,25], cited above, among others
e.g., [63], can be considered to fall within the penumbra
of the mammalian Argonaute field. It may be an inter-
esting question to examine whether different scientific
questions vary in the relative size and nature of their
penumbras, and if so, whether characterizing the pen-
umbra gives insight into features such as the growth of
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Endnote
aMost Gram-negative bacteria and some Gram-positive
bacteria secrete outer membrane vesicles (OMVs), which
are similar to exosomes in size and which contain phos-
pholipids, proteins, and lipopolysaccharides as well as
DNA [64,65]. DNA in OMVs is generally thought to be
double stranded, derived from both plasmids and chro-
mosome, and varying from ~500 bp to more than 3 kb
[66,67]. In some species OMVs can release their contents
inside targeted bacteria [68,69]; reviewed in [64]. There
are broad similarities between eukaryotic and prokaryotic
vesicles as mediators of inter-cellular communication
[70,71], and as just reviewed, both mammalian vesicles
and bacterial OMVs can transfer DNA to recipient cells.
There are broad similarities between eukaryotic and pro-
karyotic vesicles as mediators of inter-cellular communi-
cation [70,71], and as just reviewed, both mammalian
vesicles and bacterial OMVs can transfer DNA to reci-
pient cells. Yet to our knowledge, no one has investi-
gated further parallels, such as whether OMVs express
Argonaute proteins (or even if they express specific
RNAs). Nor has anyone asked whether OMVs express
short DNAs that might potentially serve as guides for
prokaryotic DNA interference. For example, no one has
examined OMVs to see if they express Argonaute pro-
teins (or even if they express specific RNAs). Nor has
anyone asked whether OMVs express short DNAs that
might potentially serve as guides for prokaryotic DNA
interference.
Reviewers’ comments
Reviewer’s report 1: Eugene Koonin, National Center for
Biotechnology Information
This is an exceptionally lively article that challenges the
common wisdom that eukaryotic Argonaute proteins
can only use small RNA guides to cleave or regulate other
RNAs. The recent demonstration that some of the pro-
karyotic Argonautes employ DNA guides prompts the
authors to consider various scenarios under which Ar-
gonaute binding to DNA could be biologically relevant.
It is particularly interesting that the amount of DNA-
containing vesicles greatly increases in cancers, suggest-
ing the possibility for important roles of Argonautes in
tumorigenesis.
I agree with the authors that the apparent current
consensus on the exclusive RNA utilization of eukaryotic
Argonautes, despite the available biochemical data on
DNA-binding, is based more on non-critically accepted
dogma than on solid negative results. The possibility of
DNA-related functions of eukaryotic Argonautes is im-
portant and certainly merits experimental investigation.I should note that this article reads to me more like
Hypothesis than a Comment. Furthermore, in my view,
the structuring of the abstract into Background, Results
and Conclusions is slightly misleading. The paper does
not really report results but a hypothesis, so either an
unstructured abstract or one divided into Background,
Presentation of the hypothesis and Testing the hypo-
thesis, would be more appropriate.
Authors’ response: In the revised version of this manu-
script, we have created an unstructured abstract. The
reasons why we prefer the Comment format rather than
Hypothesis are discussed following Dr. Makarova’s review.
Reviewer’s report 2: Kira S. Makarova, National Center for
Biotechnology Information
Drs. Smalheiser and Gomes described a hypothesis sug-
gesting that in pathological conditions specifically in
cancer cells short DNAs might displace normal RNAs
associated with of eukaryotic Argonauts and thus disrupt
important regulatory networks. In principle this is a non-
controversial and falsifiable hypothesis and in a sense an
example of the thinking outside the box. This being said
along with several methodological and philosophical is-
sues of scientific research mentioned throughout the text
of the paper there is yet another one - the absence of an
objective way to assess the strength of a hypothesis and
thus judge if the hypothesis is worth an attention of the
wide scientific audience. Often an “interesting” hypothesis
relies on the statements/observations the connection be-
tween which is not direct and obvious otherwise it be-
comes trivial. Here for example authors link the presence
of elevated amounts of the DNA in cancer cells and ability
of Argonauts to bind DNA. These are two indirect obser-
vations and connection between them is not apparent.
Back to the hypothesis strength. In my opinion it is gener-
ally determined by two criteria: 1) how detailed and mech-
anistically elaborated the hypothesis is and 2) how likely
are alternative hypotheses/explanations of the observa-
tions which is in turn directly related to the complexity of
the phenomenon in question (if it is complex there is a
large network of observations any subset of which can be
logically connected and can be equally likely). It is quite
clear that cancer pathogenesis is extremely complex
phenomenon with numerous changes in many cellular
processes and molecular interactions not mentioning that
there are different types of cancers that have considerably
different phenotypes. At least several different cancer
agents are known and therefore we may expect that mo-
lecular processes leading to the pathology would be quite
different too. Since it is complex it is quite easy to build
numerous hypotheses explaining any part of the pheno-
menon (with and without involvement of Argonaut DNA
or RNA) and even find the considerable amount of
the literature that reports the observations of a choice.
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be weak.
Now the mechanistic details. Authors suggest a very
simple mechanism of Argonaut involvement –DNA repla-
ces RNA and Argonaut stops regulating gene expression
in a proper way. This is an absolutely realistic mechanism
and authors present quite a detailed and convincing ana-
lysis with many evidence from the literature suggesting
that DNA which Argonaut can potentially bind is present
in both normal and cancer cell. However it appears that
DNA does not displace RNA in Argonauts (since their
normal function involve RNA species) in normal cells and
all the evidence which is relevant to the cancer cells men-
tioned in the text seems to come from the cell that are
already seriously and irreversibly damaged and it does not
matter in this case if Argonaut binds DNA or not too
many things went wrong already. So the main question is
if the DNA accumulation capable to disrupt normal Argo-
naut function occurs before or after irreversible damage of
other cell systems caused by malfunctioning of other cell
components. Is there any data on dynamics of key compo-
nents (including relevant RNA) involved in the proposed
mechanism along with indicators of the disruption of nor-
mal cell function? Even if a lot of DNA present in the
cytoplasm are there any indications that it is accessible for
Argonaut and not bound already by numerous DNA bind-
ing proteins? These are important details that if supportive
could make the hypothesis stronger.
Authors’ response: We are grateful to receive the com-
ments of Dr. Makarova (and Koonin), who are truly
knowledgeable and appropriate reviewers for this article.
In the revised version of this manuscript, we have ex-
panded the discussion of more general issues related to
scientific hypothesis formation and assessment which
underlie and drive this article. It is important to note
that we view this article not simply as presenting a spe-
cific hypothesis (Ago binds DNA in cancer cells), which
would be best categorized as a Hypothesis article, but as
presenting a case study of a scientific question which is
in a state of “negative consensus”. We explore the rea-
sons for this negative consensus, demonstrate the lack of
actual experimental data supporting the negative con-
sensus, and carry out a far-reaching manual search of
the literature to uncover circumstantial evidence that
makes the possibility of Ago binding DNA at least plaus-
ible and worth exploring, in a variety of biological con-
texts. All of these analyses are relevant to our article. In
this regard, the revised article points out explicitly what
was previously only hinted at: that the far-ranging and
rather open-ended literature searches constitute raw
material for studying how to create new informatics
tools that can assist investigators in the future.
Dr. Makarova has raised a number of potential objec-
tions and pointed out potential weaknesses of the notionthat Ago might bind DNA in cancer cells. We agree that
such cells are subject to multiple (and progressive) alter-
ations in signaling pathways and genome modifications,
and it is uncertain what effects would be produced by al-
tering Ago-RNA interactions in cells that are already ab-
normal. On the other hand, cancer cells are not all that
seriously and irreversibly damaged – they are still able
to grow, reproduce, secrete, migrate, metastasize, and so
forth despite expressing high levels of cytoplasmic and
exosomal DNA. Therefore, it is certainly worth explor-
ing whether altering Ago-RNA interactions is an import-
ant step in cancer pathogenesis. We agree that current
knowledge does not allow us to say whether cytoplasmic
DNA is accessible for binding to Ago, but this weakness
can be “cured” by investigating further. Without formu-
lating the hypothesis in the first place, there would be
no stimulus to finding out. Going further, we agree that
current knowledge does not provide the expectation
that Ago binds DNA under physiological conditions in
“normal” cells. However, let’s remember the precedent
of growth factors, which were originally expected to be
tumor-specific, and indeed growth factors and their recep-
tors are often up-regulated in different types of cancer; yet
later these were found to be ubiquitous regulators in cell
biology. Should Ago-DNA interactions be shown to occur
in cancer cells, it will be a natural progression of the scien-
tific process to explore if this also occurs in normal cells.
Reviewer’s report 3: Alexander Maxwell Burroughs,
National Center for Biotechnology Information
(nominated by L Aravind, National Center for
Biotechnology Information)
Smalheiser and Gomes present a thoughtful and com-
pelling counterpoint to the largely “silent” consensus that
eukaryote PIWI/Ago modules are capable of binding to
only RNA-RNA duplexes as opposed to RNA-DNA hy-
brid or DNA-DNA duplexes. They outline historical rea-
sons for the lack of experimentation on such alternative
substrates point to recent developments hinting at the
possibility of eukaryotic PIWI/Ago DNA binding and de-
scribe several plausible substrates containing DNA that
could be duplex targets of the PIWI/Ago module in eu-
karyotes. More broadly the authors generalize the issue as
an example of an unfortunate kind of consensus-building
in science one based more on established thinking and
less on experimental findings.
I strongly agree this is an issue deserving of more ex-
perimental consideration and support publication of the
manuscript. I have a few recommendations and sugges-
tions which I submit could bolster/clarify the arguments
advanced in the paper.
1) One source of widespread confusion in PIWI/Ago
studies (both experimental and computational) is the
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different members of the family. The Argonaute
proper subfamily of the canonical eukaryotic PIWI/
Ago family is a more recent innovation in the
general context of PIWI/Ago evolution. Within the
ocean of eukaryotic diversity the PIWI proper
subfamily is far more widely distributed and
demonstrably closer to the DNA-binding prokaryotic
PIWI (pPIWI) proteins. Immediately the relevance to
this article is clear: despite representing a later
innovation within the AGO/PIWI superfamily
orthologs of Argonaute have been the subject of the
bulk of existing research. While it is true that PIWI
orthologs like Argonaute proper orthologs have
demonstrated roles in RNA-RNA duplex binding
(notably in ciliates and the basal diplomonad Giardia)
and the claim cannot be made that RNA-RNA duplex
binding is an evolutionary development concomitant
with the emergence of the Argonaute proper
subfamily what the manuscript states about the lack
of exploration of alternative substrates in the
Argonaute subfamily holds even more so for the
PIWI subfamily the version most closely related to the
DNA-associating pPIWI domains.
As the article discusses all eukaryotes and as many
eukaryotic lineages lack genuine Argonaute orthologs it
is necessary to mention PIWI alongside Argonaute.
I would further recommend referring to the family con-
taining the Argonaute proteins as PIWI/Ago.
2) The article could benefit from a more detailed
historical perspective regarding the substrate-
binding propensities of PIWI/Ago. The notion of a
potential DNA-associated role for the PIWI/Ago
superfamily long predates the 2009 article referenced
in the paper: it was first postulated in 2000 after
observing strong genome concordance between
RNAi components and chromatin-modifying and
splicing factors [72]. In 2005 two papers from the
Patel group clearly demonstrate the preference of
prokaryotic PIWI/Ago for binding DNA-RNA
hybrid duplexes [73,74]. It was primarily these
findings supplemented by (at the time) relatively thin
genome associations which informed the predictions
in the 2009 Makarova paper. Ultimately I think this
further underscores the blind spot potential PIWI/
Ago DNA-binding has sat in; even after clear
experimental data was presented it took ~9 years
before this line of research was advanced further!
3) I think the manuscript somewhat underplays
support found in evolutionary reasoning for
potential eukaryotic PIWI/Ago binding of
DNA-containing substrates. This is also a poorlyunderstood area in the literature as evidenced by
the direct quotations provided by the authors in
the Background section. Several recent findings
have particular relevance to this subject and could
be mentioned in the main text in support of the
central contention of the manuscript.
a) The recent identification of the prokaryotic
PIWI-RE family (distinct from the classical pPIWI
family investigated by Makarova [3] and the
subjects of all experimental testing to date
including the recent PIWI-IP pulldown
experiments). This family was the first prokaryotic
PIWI/Ago family to be unequivocally linked via
genome association with a DinG helicase and
restriction endonuclease domain to RNA-DNA
hybrid duplex binding [75]. PIWI-RE was
speculated after further analysis to most closely
approximate the ancestral PIWI module which
emerged after the fusion of the MID domain to an
RNaseH domain likely descending from the
Endonuclease B/UvrC assemblage of RNaseH
enzymes [76]. In addition an update to the
Makarova [3] analysis found in the same
Burroughs/Ando/Aravind paper clarified the
genome associations of the pPIWI family: all of the
so-called “class I” and several“class II” pPIWI
proteins are tightly-linked in operons to DNA-
processing enzymes; some of these associations
were overlooked in the 2009 Makarova paper and
some were added to genome databases in the
interim. The sum of these observations
unequivocally establishes that the ancestral PIWI/
Ago bound DNA-RNA hybrid substrate duplexes;
in other words the RNA and DNA identified in the
Olovnikov and Swarts pPIWI pulldowns are not
anomalies but rather represent the ancestral PIWI/
Ago condition. While it appears clear that a shift
genuinely occurred at some point from a
preference for a RNA-DNA hybrid substrate to a
dsRNA substrate this still suggests the ability to
bind hybrid duplexes and to a lesser degree the
potential ability to bind dsDNA duplexes may
indeed be present in eukaryotes at least in certain
conditions or contexts.
b) The discovery of the MedPIWI family a novel
PIWI/Ago family found in the Med13 protein of
the Mediator complex and conserved across
almost all eukaryotic lineages (excepting
kinetoplastids) is of particular relevance to this
discussion. If any PIWI/Ago module in
eukaryotes is a candidate to bind RNA/DNA
duplexes it would likely be the one localizing to
the transcriptional co-activating Mediator
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contact with ssDNA formed in the wake of the
opening of the transcriptional bubble [75]. While
this certainly does not preclude the possibility
that the classical eukaryotic PIWI or Ago
subfamilies are capable of binding DNA
MedPIWI nicely dovetails with the discussion in
“DNA in the nucleus and mitochondrion” section
and further evidences potential RNA-DNA
duplex binding across eukaryotic representatives
of the PIWI/Ago superfamily.Authors’ response: Dr. Burroughs has done a great ser-
vice by pointing out many aspects of PIWI/Ago that we
did not consider in the original article. This is a rich
addition and we are glad that his review will appear along-
side the published article! We have appended the articles
that he cited into our own reference list. However, the re-
view makes us realize that our own scope, expertise and
literature review was limited largely to mammalian sys-
tems. For example, we did not include Piwi proteins in the
original article because, apart from the germline, they are
relatively poorly characterized in differentiated mam-
malian tissues. There is not even a consensus regarding
which Piwi proteins are expressed in brain, for example,
or what their binding partners are, in contrast to a very
extensive body of investigations of Ago isoforms. In the
revised version, we have changed the word Eukaryotic to
Mammalian in the title to better reflect the scope.
Reviewer’s report 4: Isidore Rigoutsos, Jefferson Medical
College
In this manuscript the authors discuss the possibility
that Ago binds DNA and that these interactions are bio-
logically meaningful. The likelihood that in certain set-
tings Ago:DNA binding interactions could compete with
or even displace Ago:RNA interactions is certainly very
intriguing and warrants further exploration. The authors
have carefully built an argument in support of this possi-
bility through a search of the literature. It is rather un-
fortunate that the field on more than one occasion has
ignored the available data, in this and in other contexts.
The authors should consider including in their references
two brief articles from the April 01 2010 issue of Nature
entitled “Hypotheses first” and “Data first” [77,78].
Interestingly enough there are also several ‘mirror’
examples in the literature of DNA binding proteins in-
teracting with RNA. For examples, RNA polymerase II
(POLR2), SMAD1, and the ZPF36/ZPF36L1/ZPF36L2
members of the tristetraprolin family are known to be
transcription factors and to bind to DNA. However some
of these proteins can bind both DNA and RNA with ex-
amples going back more than 10 years (e.g. Gallia et al.
NAR 2000, Krishna et al. NAR 2003, BabuRajendran et al.NAR 2012, etc.). More recently, DiRuscio et al. Nature
2013 showed that DNMT1 can also bind numerous
distinct RNAs.
I view all of these mirror examples as more arguments
in support of the authors’ conjecture. There is a prece-
dent of discoveries that can happen when researchers
start thinking unconventionally and give more weight to
the data in front of them. In that spirit, this thought
provoking manuscript is a well-documented ‘call to
arms’ that is bound to resonate with more than a few of
the community’s practitioners.
Authors’ response: Dr. Rigoutsos situates our Comment
very broadly in terms of hypothesis-driven vs. data-driven
approaches to science. As suggested, we have appended
the suggested citations to our paper [77,78]. It is worth
clarifying, however, that our Comment is not intended as
a critique or criticism of the mainstream approaches to
investigating eukaryotic Ago and its functions. He also
points out that Ago-DNA binding would represent just
one example among many in which proteins traditionally
thought of as RNA-binding interact with DNA, or DNA-
binding proteins interact with RNAs. We agree e.g., [79].
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